Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma

Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma

Abstract Cholangiocarcinoma (CCA) is an aggressive solid tumour with a 5-year survival rate ranging from 7% to 20%. It is, therefore, urgent to identify novel biomarkers and therapeutic targets to improve the outcomes of patients with CCA. SPRY-domain containing protein 4 (SPRYD4) contains SPRY doma...

Full description

Bibliographic Details
Main Authors: Zuyi Ma, Tiange Xie, Jia Sun, Jianchun Yu, Shanzhou Huang, Qi Zhou, Binglu Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
SPRYD4
Cholangiocarcinoma
Tumor suppressor
Prognosis
Tumor immune infiltration
Online Access:https://doi.org/10.1186/s12885-023-10810-9

Internet

https://doi.org/10.1186/s12885-023-10810-9

Similar Items